13-THY-03-AZ (D4203C00011) [VERIFY]Phase III Study of Vandetanib in Advanced Radioiodine Refractory Thyroid Cancers

Ain, Kenneth (PI)

Markey Cancer Center / Cancer Research Priority Initiative

1 Finished

1 results

Finished

Residual Scope: 13-THY-03-AZ (D4203C00011) [VERIFY]Phase III Study of Vandetanib in Advanced Radioiodine Refractory Thyroid Cancers
Ain, K.
7/1/17 → 11/29/21
Project: Research project